Group by:
Date |
Item TypeArticle
Thioredoxin reductase, an emerging target for anticancer metallodrugs. Enzyme inhibition by cytotoxic gold(III) compounds studied with combined mass spectrometry and biochemical assays.
Gabbiani, C., Mastrobuoni, G., Sorrentino, F., Dani, B., Rigobello, M.P., Bindoli, A., Cinellu, M.A., Pieraccini, G., Messori, L. and Casini, A.
MedChemComm 2
(1): 50-54.
January 2011
This list was generated on Mon Jun 23 08:32:14 2025 UTC.
![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
![[up]](/style/images/multi_up.png)
Up a level
